Literature DB >> 19442755

April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission.

Nadia Naffakh1, Sylvie van der Werf.   

Abstract

A swine-origin influenza A(H1N1) virus is currently responsible for an outbreak of infections in the human population, with laboratory-confirmed cases reported in several countries and clear evidence for human-to-human transmission. We provide a description of the outbreak at the end of April 2009, and a brief review of the zoonotic potential of swine influenza viruses.

Entities:  

Mesh：

Year:  2009        PMID： 19442755     DOI： 10.1016/j.micinf.2009.05.002

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  27 in total

1.  Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.

Authors:  Tülin Morçӧl; Brett L Hurst; E Bart Tarbet
Journal:  Vaccine       Date:  2017-07-14       Impact factor: 3.641

2.  Genetic diversity of hemagglutinin gene of A(H1N1)pdm09 influenza strains isolated in Taiwan and its potential impact on HA-neutralizing epitope interaction.

Authors:  Krzysztof Łepek; Beata Pająk; Paweł Siedlecki; Marcin Niemcewicz; Janusz Kocik; Ho-Sheng Wu; Ji-Rong Yang; Krzysztof Kucharczyk; Bogusław Szewczyk
Journal:  Hum Vaccin Immunother       Date:  2014-01-09       Impact factor: 3.452

Review 3.  Swine-origin H1N1 influenza A virus and dental practice: a critical review.

Authors:  Poramate Pitak-Arnnop; Stefan Schubert; Kittipong Dhanuthai; Kraison Sappayatosok; Ute Bauer; Pichit Ngamwannagul; Uwe Gerd Liebert; Alexander Hemprich
Journal:  Clin Oral Investig       Date:  2010-02       Impact factor: 3.573

4.  Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China.

Authors:  Wei Cui; Hongwen Zhao; Xu Lu; Ying Wen; Ying Zhou; Baocheng Deng; Yu Wang; Wen Wang; Jian Kang; Pei Liu
Journal:  BMC Infect Dis       Date:  2010-05-31       Impact factor: 3.090

5.  Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.

Authors:  Fu-Shi Quan; Aswani Vunnava; Richard W Compans; Sang-Moo Kang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

6.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in an university hospital of Morocco.

Authors:  Maha Louriz; Chafiq Mahraoui; Abderrahim Azzouzi; Mohamed Taoufiq El Fassy Fihri; Amine Ali Zeggwagh; Khalid Abidi; Driss Ferhati; Salma Echcherif El Kettani; Rajae Tachinante; Jihane Belayachi; Aicha Zekraoui; Yasser Sefiani; Al Mountacer Charif Chefchaouni; Redouane Abouqal
Journal:  Int Arch Med       Date:  2010-10-27

7.  Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality.

Authors:  Xiuming Xi; Yuan Xu; Li Jiang; Ang Li; Jie Duan; Bin Du
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

8.  Finding a new drug and vaccine for emerging swine flu: what is the concept?

Authors:  Viroj Wiwanitkit
Journal:  Biologics       Date:  2009-09-15

9.  The novel influenza A (H1N1) virus pandemic: An update.

Authors:  N Petrosillo; S Di Bella; C M Drapeau; E Grilli
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

10.  Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009.

Authors:  Cao Bin; Li Xingwang; Shu Yuelong; Jiang Nan; Chen Shijun; Xu Xiayuan; Wang Chen
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.